Regulated Information - Global

Regulated Information

Period

recent search

Showing: 105 of 156 Regulated Information

Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology, strengthening its pipeline
Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology, strengthening its pipeline

PARIS AND MARSEILLE, FRANCE, 22 October 2025 – Ipsen (Euronext: IPN; ADR: IPSEY) and ImCheck Therapeutics today announced they have entered into a definitive share purchase agreement in which Ipsen will acquire all issued and outstanding shares of ImCheck Therapeutics,…


IPSEN - Buy-back programme - Art 5 of MAR - Week 42 - 2025
IPSEN – Buy-back programme – Art 5 of MAR – Week 42 – 2025


IPSEN - Buy-back programme - Art 5 of MAR - Week 41 - 2025
IPSEN – Buy-back programme – Art 5 of MAR – Week 41 – 2025


IPSEN - Buy-back programme - Art 5 of MAR - Week 40 - 2025
IPSEN – Buy-back programme – Art 5 of MAR – Week 40 – 2025


Ipsen - September 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
Ipsen – September 2025 – Monthly information relative to the total number of voting rights and shares composing the share capital

Monthly information relative to the total number of voting rights and shares composing the share capital


1 2 3 4 32
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.